A detailed history of Two Seas Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Two Seas Capital LP holds 9,724,893 shares of ROIV stock, worth $113 Million. This represents 37.75% of its overall portfolio holdings.

Number of Shares
9,724,893
Previous 10,318,764 5.76%
Holding current value
$113 Million
Previous $109 Million 2.89%
% of portfolio
37.75%
Previous 43.6%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.17 - $12.5 $6.04 Million - $7.42 Million
-593,871 Reduced 5.76%
9,724,893 $112 Million
Q2 2024

Aug 14, 2024

BUY
$10.36 - $11.74 $24.7 Million - $28 Million
2,388,415 Added 30.12%
10,318,764 $109 Million
Q1 2024

May 15, 2024

SELL
$9.87 - $11.8 $5.7 Million - $6.82 Million
-577,874 Reduced 6.79%
7,930,349 $83.6 Million
Q4 2023

Feb 14, 2024

BUY
$8.38 - $11.58 $4.97 Million - $6.87 Million
592,991 Added 7.49%
8,508,223 $95.5 Million
Q3 2023

Nov 14, 2023

BUY
$9.76 - $13.19 $55,056 - $74,404
5,641 Added 0.07%
7,915,232 $92.4 Million
Q2 2023

Aug 14, 2023

BUY
$7.09 - $10.08 $726,611 - $1.03 Million
102,484 Added 1.31%
7,909,591 $79.7 Million
Q1 2023

May 15, 2023

BUY
$6.92 - $9.98 $9.66 Million - $13.9 Million
1,396,667 Added 21.79%
7,807,107 $57.6 Million
Q4 2022

Feb 14, 2023

BUY
$3.36 - $7.99 $1.82 Million - $4.32 Million
540,750 Added 9.21%
6,410,440 $51.2 Million
Q3 2022

Nov 14, 2022

BUY
$0.51 - $4.84 $1.25 Million - $11.9 Million
2,449,854 Added 71.64%
5,869,690 $18.9 Million
Q2 2022

Aug 12, 2022

BUY
$2.81 - $4.84 $7.34 Million - $12.6 Million
2,612,929 Added 323.82%
3,419,836 $13.9 Million
Q1 2022

May 13, 2022

BUY
$4.74 - $9.91 $2.35 Million - $4.91 Million
495,862 Added 159.42%
806,907 $3.99 Million
Q4 2021

Feb 14, 2022

BUY
$5.86 - $13.52 $1.82 Million - $4.21 Million
311,045 New
311,045 $3.14 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.15B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Two Seas Capital LP Portfolio

Follow Two Seas Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Seas Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Seas Capital LP with notifications on news.